2m 2m 2m 2m 2m 2m 2m
OS THERAP (OSTX)
NYSE
$1.63+$0.009 (+0.56%)
Price as of Jul 14, 2026 9:24 AM EDT- $72.2MMarket Cap
- 3.85%1-Year Change
- BiotechnologyIndustry
OS THERAP (OSTX)
$1.63+$0.009 (+0.56%)
OSTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.62 | ||
Change | -$0.06 (-3.57%) | ||
Open | $1.68 | ||
High | $1.69 | ||
Low | $1.61 | ||
Previous Close | $1.68 | ||
Volume | 636,227 | ||
30-Day Average Volume | 967,747 | ||
1-Week Change | 0.62% | ||
1-Month Change | -4.71% | ||
1-Year Change | 3.85% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.5M | ||
Total Assets | $7.3M | ||
Market Cap | $72.2M | ||
Enterprise Value | $72.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.4M | ||
Free Cash Flow | -$4.6M | ||
EBIT | -$10.4M | ||
EBITDA | -$10.3M | ||
Net Working Capital | -$16.0M | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -7 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue